Mesenchymal stromal cells: Sensors and switchers of inflammation

Cell Stem Cell

Volumn 13, Issue 4, 2013, Pages 392-402

  Bernardo, Maria Ester ^a   Fibbe, Willem E ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENZYME; INDOLAMINE 2,3 DIOXYGENASE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; CELL THERAPY; CELLULAR IMMUNITY; EX VIVO STUDY; GRAFT VERSUS HOST REACTION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; MACROPHAGE; MESENCHYMAL STROMA CELL; MICROENVIRONMENT; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SENSOR; ANIMAL; CYTOLOGY; METABOLISM;

ANIMALS; HUMANS; INFLAMMATION; MESENCHYMAL STROMAL CELLS;

EID: 84885099905     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2013.09.006     Document Type: Review

References (88)

1. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822
2. K. Akiyama, C. Chen, D. Wang, X. Xu, C. Qu, T. Yamaza, T. Cai, W. Chen, L. Sun, and S. Shi Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis Cell Stem Cell 10 2012 544 555
3. L.M. Ball, M.E. Bernardo, H. Roelofs, M.J. van Tol, B. Contoli, J.J. Zwaginga, M.A. Avanzini, A. Conforti, A. Bertaina, and G. Giorgiani Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease Br. J. Haematol. 2013 10.1111/bjh.12545 in press. Published online August 31, 2013
4. U. Ben-David, Y. Mayshar, and N. Benvenisty Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells Cell Stem Cell 9 2011 97 102
5. M.E. Bernardo, N. Zaffaroni, F. Novara, A.M. Cometa, M.A. Avanzini, A. Moretta, D. Montagna, R. Maccario, R. Villa, and M.G. Daidone Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms Cancer Res. 67 2007 9142 9149
6. L. Biancone, S. Bruno, M.C. Deregibus, C. Tetta, and G. Camussi Therapeutic potential of mesenchymal stem cell-derived microvesicles Nephrol. Dial. Transplant. 27 2012 3037 3042
7. S. Brandau, M. Jakob, H. Hemeda, K. Bruderek, S. Janeschik, F. Bootz, and S. Lang Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge J. Leukoc. Biol. 88 2010 1005 1015
8. S.P. Burr, F. Dazzi, and O.A. Garden Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance? Immunol. Cell Biol. 91 2013 12 18
9. C. Campagnoli, I.A. Roberts, S. Kumar, P.R. Bennett, I. Bellantuono, and N.M. Fisk Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow Blood 98 2001 2396 2402
10. E.D. Carosella, B. Favier, N. Rouas-Freiss, P. Moreau, and J. Lemaoult Beyond the increasing complexity of the immunomodulatory HLA-G molecule Blood 111 2008 4862 4870
11. F. Casiraghi, N. Perico, and G. Remuzzi Mesenchymal stromal cells to promote solid organ transplantation tolerance Curr. Opin. Organ Transplant. 18 2013 51 58
12. M.A. Cassatella, F. Mosna, A. Micheletti, V. Lisi, N. Tamassia, C. Cont, F. Calzetti, M. Pelletier, G. Pizzolo, and M. Krampera Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils Stem Cells 29 2011 1001 1011
13. A. Chaudhry, and A.Y. Rudensky Control of inflammation by integration of environmental cues by regulatory T cells J. Clin. Invest. 123 2013 939 944
14. L. Chen, E.E. Tredget, P.Y. Wu, and Y. Wu Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing PLoS ONE 3 2008 e1886
15. H. Choi, R.H. Lee, N. Bazhanov, J.Y. Oh, and D.J. Prockop Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages Blood 118 2011 330 338
16. E.W. Choi, I.S. Shin, S.Y. Park, J.H. Park, J.S. Kim, E.J. Yoon, S.K. Kang, J.C. Ra, and S.H. Hong Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation Arthritis Rheum 64 2012 243 253
17. R. Ciccocioppo, M.E. Bernardo, A. Sgarella, R. Maccario, M.A. Avanzini, C. Ubezio, A. Minelli, C. Alvisi, A. Vanoli, and F. Calliada Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease Gut 60 2011 788 798
18. A.J. Cutler, V. Limbani, J. Girdlestone, and C.V. Navarrete Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation J. Immunol. 185 2010 6617 6623
19. E. Dander, G. Lucchini, P. Vinci, M. Introna, F. Masciocchi, P. Perseghin, A. Balduzzi, S. Bonanomi, D. Longoni, and G. Gaipa Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring Leukemia 26 2012 1681 1684
20. F. Dazzi, L. Lopes, and L. Weng Mesenchymal stromal cells: a key player in 'innate tolerance'? Immunology 137 2012 206 213
21. O. Delarosa, W. Dalemans, and E. Lombardo Toll-like receptors as modulators of mesenchymal stem cells Front Immunol 3 2012 182
22. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P.D. Longoni, P. Matteucci, S. Grisanti, and A.M. Gianni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838 3843
23. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, Dj. Prockop, and E. Horwitz Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
24. M. Duijvestein, A.C. Vos, H. Roelofs, M.E. Wildenberg, B.B. Wendrich, H.W. Verspaget, E.M. Kooy-Winkelaar, F. Koning, J.J. Zwaginga, and H.H. Fidder Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study Gut 59 2010 1662 1669
25. M. Duijvestein, M.E. Wildenberg, M.M. Welling, S. Hennink, I. Molendijk, V.L. van Zuylen, T. Bosse, A.C. Vos, E.S. de Jonge-Muller, and H. Roelofs Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis Stem Cells 29 2011 1549 1558
26. E. Eggenhofer, and M.J. Hoogduijn Mesenchymal stem cell-educated macrophages Transp. Res. 1 2012 12
27. K. English, J.M. Ryan, L. Tobin, M.J. Murphy, F.P. Barry, and B.P. Mahon Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells Clin. Exp. Immunol. 156 2009 149 160
28. M. François, R. Romieu-Mourez, M. Li, and J. Galipeau Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation Mol. Ther. 20 2012 187 195
29. A.J. Friedenstein, U.F. Deriglasova, N.N. Kulagina, A.F. Panasuk, S.F. Rudakowa, E.A. Luriá, and I.A. Ruadkow Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method Exp. Hematol. 2 1974 83 92
30. D.I. Gabrilovich, S. Ostrand-Rosenberg, and V. Bronte Coordinated regulation of myeloid cells by tumours Nat. Rev. Immunol. 12 2013 253 268 10.1038/nri3175
31. S. Ghannam, J. Pène, G. Torcy-Moquet, C. Jorgensen, and H. Yssel Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype J. Immunol. 185 2010 302 312
32. S. Gordon, and A. Mantovani Diversity and plasticity of mononuclear phagocytes Eur. J. Immunol. 41 2011 2470 2472
33. I.K. Gratz, M.D. Rosenblum, and A.K. Abbas The life of regulatory T cells Ann. N Y Acad. Sci. 1283 2013 8 12
34. F. Guilloton, G. Caron, C. Ménard, C. Pangault, P. Amé-Thomas, J. Dulong, J. De Vos, D. Rossille, C. Henry, and T. Lamy Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes Blood 119 2012 2556 2567
35. N. Gupta, X. Su, B. Popov, J.W. Lee, V. Serikov, and M.A. Matthay Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice J. Immunol. 179 2007 1855 1863
36. S.R. Hall, K. Tsoyi, B. Ith, R.F. Padera Jr., J.A. Lederer, Z. Wang, X. Liu, and M.A. Perrella Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils Stem Cells 31 2013 397 407
37. G.I. Im, Y.W. Shin, and K.B. Lee Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 13 2005 845 853
38. N. Kawashima Characterisation of dental pulp stem cells: a new horizon for tissue regeneration? Arch. Oral Biol. 57 2012 1439 1458
39. C.-C. Ke, R.-S. Liu, A. Suetsugu, H. Kimura, J.H. Ho, O.K. Lee, and R.M. Hoffman In vivo fluorescence imaging reveals the promotion of mammary tumorigenesis by mesenchymal stromal cells PLoS ONE 8 7 2013 e69658
40. A. Keating Mesenchymal stromal cells: new directions Cell Stem Cell 10 2012 709 716
41. E. Kolaczkowska, and P. Kubes Neutrophil recruitment and function in health and inflammation Nat. Rev. Immunol. 13 2013 159 175
42. M. Krampera Mesenchymal stromal cell 'licensing': a multistep process Leukemia 25 2011 1408 1414
43. M. Krampera, S. Glennie, J. Dyson, D. Scott, R. Laylor, E. Simpson, and F. Dazzi Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide Blood 101 2003 3722 3729
44. H.M. Lazarus, O.N. Koc, S.M. Devine, P. Curtin, R.T. Maziarz, H.K. Holland, E.J. Shpall, P. McCarthy, K. Atkinson, and B.W. Cooper Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients Biol. Blood Marrow Transplant. 11 2005 389 398
45. K. Le Blanc, and D. Mougiakakos Multipotent mesenchymal stromal cells and the innate immune system Nat. Rev. Immunol. 12 2012 383 396
46. K. Le Blanc, I. Rasmusson, B. Sundberg, C. Götherström, M. Hassan, M. Uzunel, and O. Ringdén Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 2004 1439 1441
47. K. Le Blanc, F. Frassoni, L. Ball, F. Locatelli, H. Roelofs, I. Lewis, E. Lanino, B. Sundberg, M.E. Bernardo, M. Remberger Developmental Committee of the European Group for Blood and Marrow Transplantation Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study Lancet 371 2008 1579 1586
48. R.H. Lee, A.A. Pulin, M.J. Seo, D.J. Kota, J. Ylostalo, B.L. Larson, L. Semprun-Prieto, P. Delafontaine, and D.J. Prockop Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 Cell Stem Cell 5 2009 54 63
49. R.H. Lee, N. Yoon, J.C. Reneau, and D.J. Prockop Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity Cell Stem Cell 11 2012 825 835
50. O. Levy, W. Zhao, L.J. Mortensen, S. Leblanc, K. Tsang, M. Fu, J.A. Phillips, V. Sagar, P. Anandakumaran, and J. Ngai mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation Blood 2013 10.1182/blood-2013-04-495119 in press. Published online August 26, 2013
51. W. Li, G. Ren, Y. Huang, J. Su, Y. Han, J. Li, X. Chen, K. Cao, Q. Chen, and P. Shou Mesenchymal stem cells: a double-edged sword in regulating immune responses Cell Death Differ. 19 2012 1505 1513
52. G. Lucchini, M. Introna, E. Dander, A. Rovelli, A. Balduzzi, S. Bonanomi, A. Salvadè, C. Capelli, D. Belotti, and G. Gaipa Platelet-lysate- expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population Biol. Blood Marrow Transplant. 16 2010 1293 1301
53. Y. Luo, Y. Wang, J.A. Poynter, M.C. Manukyan, J.L. Herrmann, A.M. Abarbanell, B.R. Weil, and D.R. Meldrum Pretreating mesenchymal stem cells with interleukin-1β and transforming growth factor-β synergistically increases vascular endothelial growth factor production and improves mesenchymal stem cell-mediated myocardial protection after acute ischemia Surgery 151 2012 353 363
54. R. Maccario, M. Podestà, A. Moretta, A. Cometa, P. Comoli, D. Montagna, L. Daudt, A. Ibatici, G. Piaggio, and S. Pozzi Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype Haematologica 90 2005 516 525
55. A.M. Madec, R. Mallone, G. Afonso, E. Abou Mrad, A. Mesnier, A. Eljaafari, and C. Thivolet Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells Diabetologia 52 2009 1391 1399
56. A. Mantovani MSCs, macrophages, and cancer: a dangerous ménage-à-trois Cell Stem Cell 11 2012 730 732
57. A. Mantovani, S.K. Biswas, M.R. Galdiero, A. Sica, and M. Locati Macrophage plasticity and polarization in tissue repair and remodelling J. Pathol. 229 2013 176 185
58. S.M. Melief, C.L.M. Schrama, M.H. Brugman, M.M. Tiemessen, M.J. Hoogduijn, W.E. Fibbe, and H. Roelofs Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes towards anti-inflammatory macrophages Stem Cells 2013 10.1002/stem.1432 in press. Published online May 27, 2013
59. S.M. Melief, S.B. Geutskens, W. Fibbe, and H. Roelofs Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6 Haematologica 98 2013 888 895
60. M. Miura, Y. Miura, H.M. Padilla-Nash, A.A. Molinolo, B. Fu, V. Patel, B.M. Seo, W. Sonoyama, J.J. Zheng, and C.C. Baker Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation Stem Cells 24 2006 1095 1103
61. I.F. Mo, K.H. Yip, W.K. Chan, H.K. Law, Y.L. Lau, and G.C. Chan Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors BMC Cell Biol. 9 2008 52
62. M. Najar, G. Raicevic, H.I. Boufker, H. Fayyad Kazan, C. De Bruyn, N. Meuleman, D. Bron, M. Toungouz, and L. Lagneaux Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources Cell. Immunol. 264 2010 171 179
63. K. Németh, A. Leelahavanichkul, P.S. Yuen, B. Mayer, A. Parmelee, K. Doi, P.G. Robey, K. Leelahavanichkul, B.H. Koller, and J.M. Brown Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production Nat. Med. 15 2009 42 49
64. K. Nemeth, B. Mayer, and E. Mezey Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands J. Mol. Med. 88 2010 5 10
65. D. Park, J.A. Spencer, B.I. Koh, T. Kobayashi, J. Fujisaki, T.L. Clemens, C.P. Lin, H.M. Kronenberg, and D.T. Scadden Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration Cell Stem Cell 10 2012 259 272
66. D.G. Phinney, G. Kopen, R.L. Isaacson, and D.J. Prockop Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation J. Cell. Biochem. 72 1999 570 585
67. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
68. D. Polchert, J. Sobinsky, G. Douglas, M. Kidd, A. Moadsiri, E. Reina, K. Genrich, S. Mehrotra, S. Setty, B. Smith, and A. Bartholomew IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease Eur. J. Immunol. 38 2008 1745 1755
69. D.J. Prockop, and J.Y. Oh Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation Mol. Ther. 20 2012 14 20
70. D.J. Prockop, M. Brenner, W.E. Fibbe, E. Horwitz, K. Le Blanc, D.G. Phinney, P.J. Simmons, L. Sensebe, and A. Keating Defining the risks of mesenchymal stromal cell therapy Cytotherapy 12 2010 576 578
71. G. Raicevic, R. Rouas, M. Najar, P. Stordeur, H.I. Boufker, D. Bron, P. Martiat, M. Goldman, M.T. Nevessignsky, and L. Lagneaux Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells Hum. Immunol. 71 2010 235 244
72. S.H. Ranganath, O. Levy, M.S. Inamdar, and J.M. Karp Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease Cell Stem Cell 10 2012 244 258
73. G. Ren, L. Zhang, X. Zhao, G. Xu, Y. Zhang, A.I. Roberts, R.C. Zhao, and Y. Shi Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide Cell Stem Cell 2 2008 141 150
74. G. Ren, X. Zhao, Y. Wang, X. Zhang, X. Chen, C. Xu, Z.R. Yuan, A.I. Roberts, L. Zhang, and B. Zheng CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα Cell Stem Cell 11 2012 812 824
75. B. Sacchetti, A. Funari, S. Michienzi, S. Di Cesare, S. Piersanti, I. Saggio, E. Tagliafico, S. Ferrari, P.G. Robey, M. Riminucci, and P. Bianco Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment Cell 131 2007 324 336
76. D. Sarkar, P.K. Vemula, W. Zhao, A. Gupta, R. Karnik, and J.M. Karp Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting Biomaterials 31 2010 5266 5274
77. Z. Selmani, A. Naji, I. Zidi, B. Favier, E. Gaiffe, L. Obert, C. Borg, P. Saas, P. Tiberghien, and N. Rouas-Freiss Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells Stem Cells 26 2008 212 222
78. C. Shi, T. Jia, S. Mendez-Ferrer, T.M. Hohl, N.V. Serbina, L. Lipuma, I. Leiner, M.O. Li, P.S. Frenette, and E.G. Pamer Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands Immunity 34 2011 590 601
79. Y. Shi, J. Su, A.I. Roberts, P. Shou, A.B. Rabson, and G. Ren How mesenchymal stem cells interact with tissue immune responses Trends Immunol. 33 2012 136 143
80. J. Stagg, and J. Galipeau Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation Curr. Mol. Med. 13 2013 856 867
81. M. Sudres, F. Norol, A. Trenado, S. Grégoire, F. Charlotte, B. Levacher, J.J. Lataillade, P. Bourin, X. Holy, and J.P. Vernant Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice J. Immunol. 176 2006 7761 7767
82. K. Tarte, J. Gaillard, J.J. Lataillade, L. Fouillard, M. Becker, H. Mossafa, A. Tchirkov, H. Rouard, C. Henry, M. Splingard Société Française de Greffe de Moelle et Thérapie Cellulaire Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation Blood 115 2010 1549 1553
83. V. Tisato, K. Naresh, J. Girdlestone, C. Navarrete, and F. Dazzi Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease Leukemia 21 2007 1992 1999
84. J. Tolar, A.J. Nauta, M.J. Osborn, A. Panoskaltsis Mortari, R.T. McElmurry, S. Bell, L. Xia, N. Zhou, M. Riddle, and T.M. Schroeder Sarcoma derived from cultured mesenchymal stem cells Stem Cells 25 2007 371 379
85. S.L. Tomchuck, K.J. Zwezdaryk, S.B. Coffelt, R.S. Waterman, E.S. Danka, and A.B. Scandurro Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses Stem Cells 26 2008 99 107
86. R.S. Waterman, S.L. Tomchuck, S.L. Henkle, and A.M. Betancourt A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype PLoS ONE 5 2010 e10088
87. H. Yamane, and W.E. Paul Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets Immunol. Rev. 252 2013 12 23
88. R. Yañez, M.L. Lamana, J. García-Castro, I. Colmenero, M. Ramírez, and J.A. Bueren Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease Stem Cells 24 2006 2582 2591